Figure 1. Activity found in nose swabs and early faecal excretion for each subject at the MOX facilities. From: Practical action levels for chelation therapy.

Slides:

Advertisements

Similar presentations

Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L.

Advertisements

Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11): October 17, 2005 © The Author Published by Oxford University.

Disorders of cognitive and affective development in cerebellar malformations by Alessandro Tavano, Rita Grasso, Chiara Gagliardi, Fabio Triulzi, Nereo.

Fig. 1. Flow diagram of study participants and outcomes.

From: An open day in the metric space

Figure 4. NMDAR subunit protein levels in control and schizophrenic subjects. Scatter plots showing (A) NR1, (B) NR3A, and (C) NR3A/NR1. Small circles.

Figure 3. Day 2 cell symmetry

Figure 2 Effects of political reforms on tariff reduction and political approval rating. From: TPP negotiations and political economy reforms in Japan’s.

Fig. 1. Top-level classes of SBRML-OM.

Figure 2. CONSORT flow diagram.

Figure 3. Count rates at the eight measurement locations at ZWILAG in the vicinity of a cask filled with spent fuel (left column) and a cask containing.

From: North Korea's foreign economic relations

Figure 2. Dose distribution function for thyroid cancer cases and for healthy members of the cohort for adults (18 y of age and older at the time of the.

Figure 3. Average response time by signal-to-noise ratio (SNR), group, and condition. Error bars represent standard error. Response time was measured as.

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1 Individual Lifted from Group Photograph

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 4. p-Values from Larsson et al

Figure 1. Nonadherence to guidelines for prescribing antiplatelet and anticoagulant therapy in 144 patients with atrial fibrillation who attend a Spanish.

Figure 2 Distribution of Annual Household Income for Jordan Overall, Camp Refugees, and Camp Poor From: A Profile of Poverty for Palestinian Refugees in.

Fig. 1. The required sample sizes nPPV and nNPV versus the sample allocation fraction P for the case study. From: Sample size for.

From: Estimating the Location of World Wheat Price Discovery

Figure 1. Publication channels used by scholars at the faculty of Arts, 2006–2013. From: Accountability in context: effects of research evaluation systems.

Figure 1: Time points at which sperm samples were analysed for aneuploidy frequencies in controls and cancer patients From: Sperm aneuploidy frequencies.

Figure 2. Entrance dose at the detector for the clinical (light grey bars) and reference (dark bars) protocols. From: COMPARISON OF WIRELESS DETECTORS.

Figure 1. Variance partition for the different phases of bud and cambial phenology in black spruce provenances. From: Synchronisms between bud and cambium.

Figure 1. Example of phase shift angles among three different terns where one of them has been taken as a reference. From: Assessment of ELF magnetic fields.

FIG. 4. Working lifetime combined risk from fatal heart disease and lung cancer based on Hong Kong exposure to secondhand tobacco smoke and both US and.

Fig. 1 Languages used for SA

Figure 1. HR (95% CI) of death from dementia associated with weight or BMI in middle age and in old age. From: Adiposity in middle and old age and risk.

Figure 4. Influence of Clerk Ideology on Justice Voting.

Figure 1. Non-biochemical recurrence rate for the entire population (n = 122). From: Salvage radiation therapy for prostate cancer patients after prostatectomy.

Scheme 1. Scheme of the quartz sample holder.

Figure 3. Values of the correction factor kmtx,j for the sixty energy channels j = 1,…,60. The values for ten iteration steps are shown. In addition, the.

Figure 1 Data-selection process

Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1. Mean earnings of men and women over the early career (with 95 per cent confidence intervals) Figure 1. Mean earnings of men and women over the.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 Sources of uncertainty introduced in each stage of the standard modelling approach for estimating ... Figure 1 Sources of uncertainty introduced.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 Comparison of MITRA-FR and COAPT trial outcomes

Source: Figure created by the author based on data ...

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

Take home figure The protective role of CNP/NPR-B/NPRC.

Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.

Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs

Fig. 1 Flow chart of included patients for analyses

Fig. 1 Flow chart for selection of study subjects

Figure 1. (a) Geographical representation of sample collection area

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.

Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.

Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Patient selection

Fig. 1 A network representation of top 100 co-occurring terms

Fig. 1 Statistics of the main characters’ dialogues.

Fig. 1 Query formulation process in CLIR

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1: Trade shares of South Korea's major trading partners (% of South Korea's total trade in goods) Figure 1: Trade shares of South Korea's major.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Presentation transcript:

Figure 1. Activity found in nose swabs and early faecal excretion for each subject at the MOX facilities. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4):411-414. doi:10.1093/rpd/ncm295 Radiat Prot Dosimetry | © The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Figure 2. Activity found in nose swabs and early faecal excretion for each subject at the reprocessing plant. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4):411-414. doi:10.1093/rpd/ncm295 Radiat Prot Dosimetry | © The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Figure 3. Activity found in nose swabs and early faecal excretion for each subject at the other facilities. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4):411-414. doi:10.1093/rpd/ncm295 Radiat Prot Dosimetry | © The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Figure 4. Cumulative probability of the activity ratio of nose swabs to early faeces. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4):411-414. doi:10.1093/rpd/ncm295 Radiat Prot Dosimetry | © The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Figure 5. Relationship between activity of nose swabs and resulting effective dose for each of the subject (Figure 1–3). Parameter values (α, β) are used in case of <sup>241</sup>Pu or/and <sup>241</sup>Am in early faeces being not available. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4):411-414. doi:10.1093/rpd/ncm295 Radiat Prot Dosimetry | © The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org